Department of Neuroscience, Baylor College of Medicine, Houston, TX, USA; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA; Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, Houston, TX, 77030, USA.
Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA; Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, Houston, TX, 77030, USA.
Neurotherapeutics. 2024 Oct;21(6):e00467. doi: 10.1016/j.neurot.2024.e00467. Epub 2024 Oct 23.
Dystonia arises with cerebellar dysfunction, which plays a key role in the emergence of multiple pathophysiological deficits that range from abnormal movements and postures to disrupted sleep. Current therapeutic interventions typically do not simultaneously address both the motor and non-motor symptoms of dystonia, underscoring the necessity for a multi-functional therapeutic strategy. Deep brain stimulation (DBS) is effectively used to reduce motor symptoms in dystonia, with existing parallel evidence arguing for its potential to correct sleep disturbances. However, the simultaneous efficacy of DBS for improving sleep and motor dysfunction, specifically by targeting the cerebellum, remains underexplored. Here, we test the effect of cerebellar DBS in two genetic mouse models with dystonia that exhibit sleep defects-Ptf1a;Vglut2 and Pdx1;Vglut2-which have overlapping cerebellar circuit miswiring defects but differing severity in motor phenotypes. By targeting DBS to the fiber tracts located between the cerebellar fastigial and the interposed nuclei (FN + INT-DBS), we modulated sleep dysfunction by enhancing sleep quality and timing. This DBS paradigm improved wakefulness and rapid eye movement sleep in both mutants. Additionally, the latency to reach REM sleep, a deficit observed in human dystonia patients, was reduced in both models. Cerebellar DBS also induced alterations in the electrocorticogram (ECoG) patterns that define sleep states. As expected, DBS reduced the severe dystonic twisting motor symptoms that are observed in the Ptf1a;Vglut2 mice. These findings highlight the potential for using cerebellar DBS to simultaneously improve sleep and reduce motor dysfunction in dystonia and uncover its potential as a dual-effect in vivo therapeutic strategy.
肌张力障碍是由小脑功能障碍引起的,小脑在多种病理生理缺陷的出现中起着关键作用,这些缺陷范围从异常运动和姿势到睡眠紊乱。目前的治疗干预通常不能同时解决肌张力障碍的运动和非运动症状,这突显了需要一种多功能的治疗策略。深部脑刺激(DBS)有效地用于减少肌张力障碍的运动症状,现有的平行证据表明其具有纠正睡眠障碍的潜力。然而,DBS 同时改善睡眠和运动功能的效果,特别是通过靶向小脑,仍然没有得到充分的探索。在这里,我们在两个具有睡眠缺陷的肌张力障碍基因小鼠模型中测试了小脑 DBS 的效果-Ptf1a;Vglut2 和 Pdx1;Vglut2-它们具有重叠的小脑回路连接错误缺陷,但运动表型的严重程度不同。通过将 DBS 靶向位于小脑 fastigial 和中间核之间的纤维束(FN + INT-DBS),我们通过提高睡眠质量和调整睡眠时机来调节睡眠功能障碍。这种 DBS 范式改善了两种突变体的觉醒和快速眼动睡眠。此外,在两种模型中,REM 睡眠潜伏期(在人类肌张力障碍患者中观察到的缺陷)也得到了缩短。小脑 DBS 还诱导了定义睡眠状态的脑电图(ECoG)模式的改变。正如预期的那样,DBS 减少了在 Ptf1a;Vglut2 小鼠中观察到的严重扭曲运动症状。这些发现强调了使用小脑 DBS 同时改善睡眠和减少肌张力障碍运动功能的潜力,并揭示了其作为一种体内双重效应治疗策略的潜力。